Taj Pharmaceuticals as Manufacturer of Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection manufacturer in India {Taj Pharmaceuticals}; best quality supplier and exporter of Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection Taj Pharmaceuticals manufactures a wide range of pharmaceuticals formulation involving // and Orals. Taj Pharma India team has an excellent expertise in manufacturing and export of Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection Taj Pharmaceuticals places its main business as a Pharmaceuticals manufacturing and exports of generic drug supply of Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection; primarily of pharmaceuticals preparations known as Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection; as well as more than 100+ generic equivalent drug. Taj Pharmaceuticals has performed these business activities related to exports of Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection for major foreign-affiliated pharmaceutical import companies, ministry of health, tenders etc. and have enjoyed the full confidence of these companies, instructions and governments. Taj Pharma Group Under close cooperation between the formulation manufacturing division, active ingredient division and the technology development division for major generic formulations such as Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection; at Taj Pharma we will appropriately meet diverse needs for Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection export manufacturing in a wide range of activities from investigation of possible formulations of Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection, formulation development, making applications to the international regulatory authorities for marketing approval, validation of Vitamin K1 (Phytomenadione) 2mg/0.2ml Injection through to manufacturing scale production at our cGMP compliant manufacturing units of Taj Pharmaceuticals under the umbrella of Taj Pharma Group. We at Taj Pharma intend to make our manufacturing systems comply with the requirements of the FDA (cGMP) such that pilot plant scale production of products in the stage of clinical development or for use in clinical studies, as well as manufacture of products in small lots are practicable to ensure a highly stable pharmaceuticals formulations of generic equivalent and bio-similar products. We conduct extensive bio-similar and bio-equivalency studies for all our formations